Background: We studied the expression of important costimulatory molecules of lymphocyte activation and the presence of CD16 + cells on aspiration biopsies of kidney transplants, measured three soluble factors and whe n indicated tested their robustness in diagnosing acute rejection. Methods : Fine-needle aspiration biopsies were performed either on days seven or 14 - 30 post-transplantation among stable kidney transplants and on the day of acute rejection diagnosis, while a sample of peripheral blood was collected simultaneously. The cyto preparations were studied by the enzymatic avidin biotin complex staining. The immunocytochemistry was directed to CD16, CD28, CD152, ICOS, CD40, CD154, CD26 and CD27. We performed the analysis in the peripheral blood by ELISA for soluble(s) CD16, CD26, and CD154. Results: The group of acute rejection cases showed a significant up-regulated expression of CD16, CD26, ICOS and CD40 as compared to the group of stable cases. Both sCD16 and sCD154 were significantly higher in the blood samples of the group with acute rejection. Thymoglobulin down-regulated CD154 and sCD16. CD16, CD26 and ICOS exhibited very high sensitivity and specificity for acute rejection diagnosis. Conclusions: The presence of CD16 + cells inside the graft emerged as a distinct player in acute rejection, confirming other previous reports whereas we first document that in human kidney transplants, ICOS and CD26 are significantly up-regulated and both reached positive predictive values for acute rejection ≥ 80%. The other costimulatory molecules, with the exception of CD40, though widely known, did not show robust association with immune events.
Medawar, P.B. (1944) The Behaviour and Fate of Skin Autografts and Skin Homografts in Rabbits. Journal of Anatomy, 78, 176. https://doi.org/10.1111/ajt.15274
Hart, A., Smith, J.M., Skeans, M.A., et al. (2019) OPTN/SRTR 2017 Annual Data Report: Kidney. American Journal of Transplantation, 19, 19-123. https://doi.org/10.1111/j.1600-6143.2011.03840.x
Sellarés, J., de Freitas, D.G., Mengel, M., et al. (2012) Understanding the Causes of Kidney Transplant Failure: The Dominant Role of Antibody-Mediated Rejection and Nonadherence. American Journal of Transplantation, 12, 388-399. https://doi.org/10.1182/asheducation-2003.1.350
Barrett, A.J., Rezvani, K., Solomon, S., et al. (2003) New Developments in Allotransplant Immunology. Hematology, ASH Education Program, 102, 350-371.
Shipkova, M. and Wieland, E. (2012) Surface Markers of Lymphocyte Activation and Markers of Cell Proliferation. Clinica Chimica Acta, 413, 1338-1349. https://doi.org/10.1016/j.cca.2011.11.006
Vincenti, F., Dritselis, A. and Kirkpatrick, P. (2011) Belatacept. Nature Reviews Drug Discovery, 10, 655-656. https://doi.org/10.1038/nrd3536
Burghuber, C.K., Manook, M., Ezekian, B., et al. (2019) Dual Targeting: Combining Costimulation Blockade and Bortezomib to Permit Kidney Transplantation in Sensitized Recipients. American Journal of Transplantation, 19, 724-736. https://doi.org/10.1111/ajt.15067
Espié, P., He, Y., Koo, P., et al. (2020) First-in-Human Clinical Trial to Assess Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Iscalimab, an Anti CD40 Monoclonal Antibody. American Journal of Transplantation, 20, 463-473. https://doi.org/10.1111/ajt.15661
Wieland, E., Shipkova, M., Martius, Y., et al. (2011) Association between Pharmacodynamic Biomarkers and Clinical Events in the Early Phase after Kidney Transplantation: A Single-Center Pilot Study. Therapeutic Drug Monitoring, 33, 341-349. https://doi.org/10.1097/FTD.0b013e3182188675
Sindhi, R., Manavalan, J.S., Magill, A., Suciu-Foca, N. and Zeevi, A. (2005) Reduced Immunosuppression in Pediatric Liver-Intestine Transplant Recipients with CD8+ CD28-T-Suppressor Cells. Human Immunology, 66, 252-257. https://doi.org/10.1016/j.humimm.2004.05.017
Ashokhumar, C., Bentlejewski, C., Sun, Q., et al. (2010) Allospecific CD154+B Cells Associate with Intestine Allograft Rejection in Children. Transplantation, 90, 1226-1231. https://doi.org/10.1097/TP.0b013e3181f995ce
Banchereau, J., Briere, F., Caux, C., et al. (2000) Immunobiology of Dendritic Cells. Annual Review of Immunology, 18, 767-811. https://doi.org/10.1146/annurev.immunol.18.1.767
Piccioli, D., Tavarini, S., Borgogni, E., et al. (2007) Functional Specialization of Human Circulating CD16 and CD1c Myeloid Dendritic-Cell Subsets. Blood, 109, 5371-5379. https://doi.org/10.1182/blood-2006-08-038422
Aguilar-Ruiz, S., Torres-Aguilar, H., González-Domínguez, E., et al. (2011) Human CD16+ and CD16? Monocyte Subsets Display Unique Effector Properties in Inflammatory Conditions in Vivo. Journal of Leukocyte Biology, 6, 1119-1131. https://doi.org/10.1189/jlb.0111022
Haÿry, P. (1989) Fine-Needle Aspiration Biopsy in Renal Transplantation. Kidney International, 36, 130-141. https://doi.org/10.1038/ki.1989.172
Xavier, P.D.P., Lema, G.L., Magalhães, M.C., et al. (2014) Flow Cytometry Assessment of Graft-Infiltrating Lymphocytes Can Accurately Identify Acute Rejection in Kidney Transplants. Clinical Transplantation, 28, 177-183. https://doi.org/10.1111/ctr.12293
Oliveira, J.G.G., Ramos, J.P., Xavier, P., Magalhães, M.C., Mendes, A.A. and Guerra, L.E.R. (1997) Analysis of Fine-Needle Aspiration Biopsies by Flow Cytometry in Kidney Transplant Patients, Transplantation, 64, 97-102. https://doi.org/10.1097/00007890-199707150-00018
Ohnuma, K., Takahashi, N., Yamochi, T., Hosono, O., Dang, N.H. and Morimoto, C. (2008) Role of CD26/Dipeptidyl Peptidase IV in Human T Cell Activation and Function. Frontiers in Bioscience, 13, 2299-2310. https://doi.org/10.2741/2844
Oliveira, J.G.G., Xavier, P., Neto, S., Mendes, A.A. and Guerra, L.E.R. (1997) Monocytes-Macrophages and Cytokines/Chemokines in Fine-Needle Aspiration Biopsy Cultures: Enhanced Interleukin-1 Receptor Antagonist in Rejection-Free Kidney Transplant Patients. Transplantation, 63, 1751-1756. https://doi.org/10.1097/00007890-199706270-00008
Everly, M.J., Everly, J.J., Arend, L.J., et al. (2009) Reducing de Novo Donor-Specific Antibody Levels during Acute Rejection Diminishes Renal Allograft Loss. American Journal of Transplantation, 9, 1063-1071. https://doi.org/10.1111/j.1600-6143.2009.02577.x
Neudoerfl, C., Mueller, B.J., Blume, C., et al. (2013) The Peripheral NK Cell Repertoire after Kidney Transplantation Is Modulated by Different Immunosuppressive Drugs. Frontiers in Immunology, 4, 46. https://doi.org/10.3389/fimmu.2013.00046
van den Bosch, T.P.P., Hilbrands, L.B., Kraaijeveld, R., et al. (2017) Pretransplant Numbers of CD16+ Monocytes as a Novel Biomarker to Predict Acute Rejection after Kidney Transplantation: A Pilot Study. American Journal of Transplantation, 17, 2659-2667. https://doi.org/10.1111/ajt.14280
Tinckam, K.J., Djurdjev, O. and Magil, A.B. (2005) Glomerular Monocytes Predict Worse Outcomes after Acute Renal Allograft Rejection Independent of C4d Status. Kidney International, 68, 1866-1874. https://doi.org/10.1111/j.1523-1755.2005.00606.x
Tuijnman, W.B., Wijngaard, P.L., van Wichen, D., van de Winkel, J.G., Capel, P.J. and Schuurman, H.J. (1992) Presence of CD16 on Endothelial Cells in Heart Transplant Rejection: An Immunohistochemical Study. Scandinavian Journal of Immunology, 35, 569-573. https://doi.org/10.1111/j.1365-3083.1992.tb03256.x
Mandelboim, O., Malik, P., Davies, D.M., Jo, C.H., Boyson, J.E. and Strominger, J.L. (1999) Human CD16 as a Lysis Receptor Mediating Natural Killer Cell Cytotoxicity. Proceedings of the National Academy of Sciences of the United States of America, 96, 5640-5644. https://doi.org/10.1073/pnas.96.10.5640
Hidalgo, L.G., Sis, B., Sellers, J., et al. (2010) NK Cell Transcripts and NK Cells in Kidney Biopsies from Patients with Donor-Specific Antibodies: Evidence for NK Cell Involvement in Antibody-Mediated Rejection. American Journal of Transplantation, 10, 1812-1822. https://doi.org/10.1111/j.1600-6143.2010.03201.x
Arnold, M.L., Kainz, A., Hidalgo, L.G., et al. (2018) Functional Fc Gamma Receptor Gene Polymorphisms and Donor-Specific Antibody-Triggered Microcirculation Inflammation. American Journal of Transplantation, 18, 2261-2273. https://doi.org/10.1111/ajt.14710
Paul, P., Pedini, P., Lyonnet, L., et al. (2019) FCGR3A and FCGR2A Genotypes Differentially Impact Allograft Rejection and Patients’ Survival after Lung Transplant. Frontiers in Immunology, 10, 1208. https://doi.org/10.3389/fimmu.2019.01208
Randolph, G.J., Jakubzick, C. and Qu, C. (2008) Antigen Presentation by Monocytes and Monocyte-Derived Cells. Current Opinion in Immunology, 20, 52-60. https://doi.org/10.1016/j.coi.2007.10.010
Grage-Griebenow, E., Zawatzky, R., Khalert, H., Brade, L., Flad, H. and Ernst, M. (2001) Identification of a Novel Dendritic Cell-Like Subset of CD64(+)/CD16(+) Blood Monocytes. European Journal of Immunology, 31, 48-56. https://doi.org/10.1002/1521-4141(200101)31:1 3.0.CO;2-5
Randolph, G.J., Sanchez-Scmitz, G., Liebman, R.M. and Schäkel, K. (2002) The CD16+ (FcRIII+) Subset of Human Monocytes Preferentially Becomes Migratory Dendritic Cells in a Model Tissue Setting. Journal of Experimental Medicine, 196, 517-527. https://doi.org/10.1084/jem.20011608
Wu, H., Malone, A.F., Donnelly, E.L., Kirita, Y., Uchimura, K., Ramakrishnan, S.M., Gaut, J.P. and Humphreys, B.D. (2018) Single-Cell Transcriptomics of a Human Kidney Allograft Biopsy Specimen Defines a Diverse Inflammatory Response. Journal of the American Society of Nephrology, 29, 2069-2080. https://doi.org/10.1681/ASN.2018020125
Shipkova, M., Krizan, E., Klett, C., Leicht, S. and Wieland, E. (2009) Effect of Immunosuppressants on CD26/Dipeptidyl Peptidase IV Expression on CD3 in Vitro. Therapeutic Drug Monitoring, 31, 660.
Kubota, T., Flentke, G.R., Bachovchin, W.W. and Stollar, B.D. (1992) Involvement of Dipeptidyl Peptidase IV in an in Vivo Immuno Response. Clinical & Experimental Immunology, 89, 192-197. https://doi.org/10.1111/j.1365-2249.1992.tb06931.x
Korom, S., De Meester, I., Stadbauer, T.H., et al. (1997) Inhibition of CD26/Dipeptidyl Peptidase IV Activity in Vivo Prolongs Cardiac Allograft Survival in Rat Recipients. Transplantation, 63, 1495-1500. https://doi.org/10.1097/00007890-199705270-00021
Zhai, W., Cardell, M., De Meester, I., et al. (2006) Ischemia/Reperfusion Injury: The Role of CD26/Dipeptidyl-Peptidase IV Inhibition in Lung Transplantation. Transplantation Proceedings, 38, 3369-3371. https://doi.org/10.1016/j.transproceed.2006.10.048
Zhao, X.Z.K., Daniel, P., Wisbrun, N., Fuchs, H. and Fan, H. (2019) Delayed Allogeneic Skin Graft Rejection in CD26-Deficient Mice. Cellular & Molecular Immunology, 16, 557-567. https://doi.org/10.1038/s41423-018-0009-z
Kirk, A.D., Tadaki, D., Celniker, A., et al. (2001) Induction Therapy with Monoclonal Antibodies Specific for CD80 and CD86 Delays the Onset of Acute Renal Allograft Rejection in Non-Human Primates. Transplantation, 72, 377-384. https://doi.org/10.1097/00007890-200108150-00005
Yamada, A., Kishimoto, K., Dong, V., et al. (2001) CD28-Independent Costimulation of T Cells in Alloimmune Responses. The Journal of Immunology, 167, 140-146. https://doi.org/10.4049/jimmunol.167.1.140
Liu, D., Krummey, S.M., Badell, I., et al. (2014) 2B4(CD244) Induced by Selective CD28 Blockade Functionally Regulates Allograft-Specific CD8+ T Cell Responses. Journal of Experimental Medicine, 211, 297-311. https://doi.org/10.1084/jem.20130902
Kitchens, W.H., Haridas, D., Wagener, M.E., et al. (2012) Integrin Antagonists Prevent Costimulatory Blockade-Resistant Transplant Rejection by CD8+ Memory T Cells. American Journal of Transplantation, 12, 69-80. https://doi.org/10.1111/j.1600-6143.2011.03762.x
He, X., Smeets, R.L., Koenen, H.J., et al. (2011) Mycophenolic Acid-Mediated Suppression of Human CD4+ T Cells: More than Mere Guanine Nucleotide Deprivation. American Journal of Transplantation, 11, 439-449. https://doi.org/10.1111/j.1600-6143.2010.03413.x
Adams, A.B., Ford, M.L. and Larsen, C.P. (2016) Costimulation Blockade in Autoimmunity and Transplantation: The CD28 Pathway. The Journal of Immunology, 197, 2045-2050. https://doi.org/10.4049/jimmunol.1601135
June, C.H., Ledbetter, J.A., Linsley, P.S. and Thompson, C.B. (1990) Role of the CD28 Receptor in T-Cell Activation. Immunology Today, 11, 211-216. https://doi.org/10.1016/0167-5699(90)90085-N
Dong, C., Juedes, A.E., Temann, U.A., Shresta, S., Allison, J.P., Ruddle, N.H. and Flavell, R.A. (2001) ICOS Costimulatory Receptor Is Essential for T-Cell Activation and Function. Nature, 409, 97-101. https://doi.org/10.1038/35051100
Liu, D., Suchard, S.J., Nadler, S.G. and Ford, M.L. (2015) Inhibition of Donor-Reactive CD8+ T Cell Responses by Selective CD28 Blockade Is Independent of Reduced ICOS Expression. PLoS ONE, 10, e0130490. https://doi.org/10.1371/journal.pone.0130490
O’Neill, N.A., Zhang, T., Braileanu, G., et al. (2018) Pilot Study of Delayed ICOS/ICOS-L Blockade with CD40 to Modulate Pathogenic Alloimmunity in a Primate Cardiac Allograft Model. Transplantation Direct, 4, e344. https://doi.org/10.1097/TXD.0000000000000761
Cantaluppi, V., Merlotti, G., Quaglia, M., et al. (2020) Activation of the ICOS/ICOS Ligand Pathway in Antibody-Mediated Kidney Graft Rejection [Abstract 244]. American Journal of Transplantation, 20.
Akalin, E., Dikman, S., Murphy, B., Bromberg, J.S. and Hancock, W.W. (2003) Glomerular Infiltration by CXCR3+ ICOS+ Activated T Cells in Chronic Allograft Nephropathy with Transplant Glomerulopathy. American Journal of Transplantation, 3, 1116-1120. https://doi.org/10.1034/j.1600-6143.2003.00151.x
Lo, D.J., Anderson, D.J., Song, M., et al. (2015) A Pilot Trial Targeting the ICOS-ICOL-L Pathway in Nonhuman Primate Kidney Transplantation. American Journal of Transplantation, 15, 984-992. https://doi.org/10.1111/ajt.13100
Renshaw, B.R., Fanslow, W.W.C., Armitage, R.J., et al. (1994) Humoral Immune Responses in CD40 Ligand-Deficient Mice. Journal of Experimental Medicine, 180, 1889-1900. https://doi.org/10.1084/jem.180.5.1889
Kawabe, T., Naka, T., Yoshida, K., et al. (1994) The Immune Responses in CD40 Deficient Mice: Impaired Immunoglobulin Class Switching and Germinal Center Formation. Immunity, 1, 167-178. https://doi.org/10.1016/1074-7613(94)90095-7
Cella, M., Scheidegger, D., Palmer-Lehmann, K., Lane, P., Lanzavecchia, A. and Alber, G. (1996) Ligation of CD40 on Dendritic Cells Triggers Production of High Levels of Interleukin-12 and Enhances T Cell Stimulatory Capacity: T-T Help via APC Activation. Journal of Experimental Medicine, 184, 747-752. https://doi.org/10.1084/jem.184.2.747
Zhang, T., Pierson III, R.N. and Azimzadeh, A.M. (2015) Update on CD40 and CD154 Blockade in Transplant Models. Immunotherapy, 7, 899-911. https://doi.org/10.2217/IMT.15.54
Hendriks, J., Xiao, Y. and Borst, J. (2003) CD27 Promotes Survival of Activated T Cells and Complements CD28 in Generation and Establishment of the Efferent T Cell Pool. Journal of Experimental Medicine, 198, 1369. https://doi.org/10.1084/jem.20030916
Denoued, J. and Moser, M. (2011) Role of CD27/CD70 Pathway of Activation in Immunity and Tolerance. Journal of Leukocyte Biology, 89, 195-203. https://doi.org/10.1189/jlb.0610351
Gravestein, L., Nieland, J.D., Kruisbeck, A. and Borst, J. (1995) Novel mAbs Reveal Potent Costimulatory Activity of Murine CD27. International Immunology, 7, 551-557. https://doi.org/10.1093/intimm/7.4.551
Barten, M.J., Dhein, S., Chang, H., et al. (2003) Assessment of Immunosuppressive Drug Interactions: Inhibition of Lymphocyte Function in Peripheral Blood. The Journal of Immunology Methods, 283, 99-114. https://doi.org/10.1016/j.jim.2003.08.015